Application of mesoporous silica nanoparticles in

HIGHLIGHTS

• who: Cancer Therapy and colleagues from the School of Chemistry and Physics, Faculty of Science, Queensland University of Technology (QUT), Brisbane, QLD, Australia have published the research work: Application of Mesoporous Silica NanopArticles in, in the Journal: Pharmaceutics 2022, 14, 1579. of /2022/
• what: The in_vitro results of this study demonstrated that the labeled human mesenchymal stem_cells with these nanoparticles had detection limits of nearly 9000 cells with no cytotoxicity at the required concentration of these nanoparticles (250 µg/mL) for labeling. The results of this study demonstrated that MSNs were efficient as theranostic agents . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.